Carolien Zeetsen

146 Le Foll, B., & Tyndale, R.F. (2015). Cannabinoids: friend or foe? Clinical Pharmacology and Therapeutics, 97 (6), 528–531. https://doi.org/10.1002/cpt.119 Leathem, J.M., Murphy, L.J., & Flett, R.A. (1998). Self– and informant–ratings on the Patient Competency Rating Scale in patients with Traumatic Brain Injury. Journal of Clinical and Experimental Neuropsychology, 20 (5), 694–705. https://doi.org/10.1076/jcen.20.5.694.1122 Lebedeva, E., Huang, M., & Koski, L. (2016). Comparison of alternate and original items on the Montreal Cognitive Assessment. Canadian Geriatrics Journal, 19 (1), 15–18. https://doi.org/10.5770/cgj.19.216 Lezak, M.D., Howieson, D.B., Bigler, E.D., & Tranel, D. (2012). Neuropsychological assessment (5th ed.). New York, Oxford University Press. Loughead, J., Wileyto, E.P., Ruparel, K., Falcone, M., Hopson, R., Gur, R., & Lerman, C. (2015). Working memory–related neural activity predicts future smoking relapse. Neuropsychopharmacology, 40 , 1311–1320. https://doi.org/10.1038/npp.2014.318 Lovibond, P.F., & Lovibond, S.H. (1995). The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behaviour Research and Therapy, 33 , 335–343. https://doi.org/10.1016/0005-7967( 94)00075-u Lundqvist, T. (2005). Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology, Biochemistry and Behavior, 81 (2), 319–330. https://doi.org/10.1016/j.pbb.2005.02.017 Lyons, M.J., Bar, J.L., Panizzon, M.S., Toomey, R., Eisen, S., Xian, H., & Tsuang, M.T. (2004). Neuropsychological consequences of regular marijuana use: a twin study. Psychological Medicine, 34 (7), 1239–1250. https://doi.org/10.1017/S0033291704002260 Lyvers, M., & Tobias–Webb, J. (2010). Effects of acute alcohol consumption on executive cognitive functioning in naturalistic settings. Addictive Behaviors, 35 (11), 1021–1028. https://doi.org/10.1016/j. addbeh.2010.06.022 Ma, B., Mei, D., Wang, F., Liu, Y., & Zhou, W. (2019). Cognitive enhancers as a treatment for heroin relapse and addiction. Pharmacological Research, 141 , 378–383. https://doi.org/10.1016/j.phrs.2019.01.025 Malek–Ahmadi, M., Powell, J.J., Belden, C.M., O’Connor, K., Evans, L., Coon, D.W., & Nieri, W. (2015). Age– and education–adjusted normative data for the Montreal Cognitive Assessment (MoCA) in older adults age 70–99. Aging, Neuropsychology, and Cognition, 22 (6), 755–761. https://doi.org/10.1080 /13825585.2015.1041449 Meyers, J.E., & Meyers, K.R. (1995). Rey Complex Figure Test and recognition trial: professional manual . Lutz, FL, PAR. Mioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J.R. (2006). The Addenbrooke’s Cognitive Examination Revised (ACE–R): a brief cognitive test battery for dementia screening. International Journal of Geriatric Psychiatry, 21 (11), 1078–1085. https://doi.org/10.1002/gps.1610 Moafmashhadi, P., & Koski, L. (2013). Limitations for interpreting failure on individual subtests of the Montreal Cognitive Assessment. Journal of Geriatric Psychiatry and Neurology, 26 (1), 19–28. https://doi.org/10.1177/0891988712473802